<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01319604</url>
  </required_header>
  <id_info>
    <org_study_id>10/01</org_study_id>
    <nct_id>NCT01319604</nct_id>
  </id_info>
  <brief_title>SENSIMED Triggerfish</brief_title>
  <official_title>Randomized Clinical Investigation to Assess the Efficacy of SENSIMED Triggerfish Continuous IOP Monitoring</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sensimed AG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sensimed AG</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the investigation is to investigate the relationship between the study device
      output and tonometric assessments.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      60 subjects will be enrolled in total. Enrolled patients will be randomized into one of 8
      device groups of 6 subjects each or into the control group containing 12 subjects. Patients
      in the device arm will receive one session of 3-to 24-hour continuous IOP monitoring with
      SENSIMED Triggerfish®. SENSIMED Triggerfish® monitoring will begin at 18h ± 2 hours for all
      patients. SENSIMED Triggerfish® will be installed randomly on right or left eyes. During
      SENSIMED Triggerfish® monitoring on one eye, GAT and/or Perkins IOP measurements will be
      taken in the fellow eye every 3 hours. Outside this time they will receive GAT and/or IOP
      measurements every 3 hours in both eyes until the end of the 24-hours period. Patients in the
      control group will receive GAT and/or ICare PRO IOP measurements every 3 hours for 24 hours
      in both eyes.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2011</start_date>
  <completion_date type="Actual">May 2012</completion_date>
  <primary_completion_date type="Actual">May 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Relationship between study device signal and tonometer reading</measure>
    <time_frame>during 24 hours of study device wear</time_frame>
  </primary_outcome>
  <number_of_arms>9</number_of_arms>
  <enrollment type="Actual">59</enrollment>
  <condition>Glaucoma</condition>
  <arm_group>
    <arm_group_label>Study device during 3 hours</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Study device during 6 hours</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Study device during 9 hours</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Study device during 12 hours</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Study device during 15 hours</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Study device during 18 hours</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Study device during 21 hours</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Study device during 24 hours</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Tonometric assessment during 24 hours</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>SENSIMED Triggerfish</intervention_name>
    <description>Soft contact lens-based device for the continuous monitoring of IOP fluctuations</description>
    <arm_group_label>Study device during 3 hours</arm_group_label>
    <arm_group_label>Study device during 6 hours</arm_group_label>
    <arm_group_label>Study device during 9 hours</arm_group_label>
    <arm_group_label>Study device during 12 hours</arm_group_label>
    <arm_group_label>Study device during 15 hours</arm_group_label>
    <arm_group_label>Study device during 18 hours</arm_group_label>
    <arm_group_label>Study device during 21 hours</arm_group_label>
    <arm_group_label>Study device during 24 hours</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Tonometer</intervention_name>
    <description>Tonometric assessment of IOP</description>
    <arm_group_label>Tonometric assessment during 24 hours</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Signed informed consent for the investigation

          -  Confirmed diagnosis of primary open angle glaucoma or normal tension glaucoma of
             similar degree in both eyes

          -  Age 18-85

          -  Stable anti-glaucomatous therapy 4 weeks before and throughout the investigation

        Exclusion Criteria:

          -  Patients not able to understand the character and individual consequences of the
             investigation

          -  Patients with contraindications for silicone contact lens wear

          -  Wear of full frame metallic glasses during SENSIMED Triggerfish® monitoring

          -  Diagnosis of pseudoexfoliation syndrome / pseudoexfoliative glaucoma and of pigment
             dispersion syndrome / pigmentary glaucoma

          -  Severe dry eye

          -  Patients who have had ocular surgery within the last 3 months

          -  Corneal or conjunctival abnormality or irregularity hindering correct contact lens
             adaptation

          -  Allergy to corneal anaesthesia

          -  Simultaneous participation in other clinical research
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Milko Iliev, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Bern</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital Leuven</name>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Glostrup</name>
      <address>
        <city>Glostrup</city>
        <zip>2600</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Clínico San Carlos</name>
      <address>
        <city>Madrid</city>
        <zip>28040</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitari i Politècnic la Fe</name>
      <address>
        <city>Valencia</city>
        <zip>46026</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Inselspital</name>
      <address>
        <city>Bern</city>
        <zip>3010</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>Denmark</country>
    <country>Spain</country>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>August 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 18, 2011</study_first_submitted>
  <study_first_submitted_qc>March 18, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 21, 2011</study_first_posted>
  <last_update_submitted>August 7, 2012</last_update_submitted>
  <last_update_submitted_qc>August 7, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 8, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

